TibaRay, Inc

Website

TibaRay, Inc TibaRay is advancing linear accelerator technology for faster, more precise radiation therapy and cancer treatment. Curing Cancer in a FLASH™.

Founded on Stanford-developed technology, we're helping shape the future of cancer care.

10/16/2026

It was great connecting with everyone at ASTRO’s 68th Annual Meeting in Boston at the end of September! Being surrounded by so many people dedicated to advancing radiation oncology is always inspiring.

We were glad to share our latest presentation on Monte Carlo Simulation and IMRT Plan Optimization for Dynamically Configurable X-ray Compensators, work that Dr. Billy Loo presented on behalf of our team.

Every conversation and scientific session is a great reminder of why we do what we do: pushing the boundaries of physics and technology to deliver faster, more precise, and effective care to cancer patients everywhere.

Thank you to everyone who stopped by to chat with us, ask great questions, or catch the presentation. It’s always energizing to spend time with this community, and we look forward to continuing these conversations in the months ahead!

Stay connected and learn more about our mission: https://na2.hubs.ly/H08r5RZ0

10/14/2026

"At age 93, going on 94, I couldn't be more proud to be a part of this." - Bill Wraith III

Serial entrepreneur, philanthropist, and early and ongoing TibaRay backer Bill Wraith recently toured our Silicon Valley headquarters in Fremont, CA, for a firsthand look at our Galactica™ linear accelerator platform in production.

Bill’s story as an investor in radiation oncology spans decades. In Accuray's early days, he helped finance the company to bring CyberKnife to market and witnessed firsthand how disruptive image-guided radiosurgery could redefine cancer care.

Why Bill Believes in TibaRay:
- "A Breakthrough in Technology & Accomplishment": Recognizing the physical engineering progress made across every step of our 24,000 sq. ft. Silicon Valley manufacturing floor.
- Unmatched Performance & Economics: Delivering higher radiation performance and economic efficiency to make curative care accessible to patients worldwide, even in remote regions.
- World-Class Leadership: Supporting a team that combines Stanford accelerator physics, radiation oncology, and proven NASDAQ-scale commercial ex*****on.

Watch the video to hear Bill share why he chose to invest in TibaRay, and see why the community is stepping up to help us redefine what is curable.

👉 Join Bill and our investor community on Wefunder: https://na2.hubs.ly/H08ncyC0

Breast Cancer Awareness Day is a powerful reminder of why we dedicate our lives to oncology innovation. Behind every sta...
10/13/2026

Breast Cancer Awareness Day is a powerful reminder of why we dedicate our lives to oncology innovation. Behind every statistic is a human story. A mother, a sister, a daughter, a friend, and an entire network of loved ones standing together in hope.

For anyone who has walked through a breast cancer diagnosis or held the hand of someone who has, you know that the journey requires unimaginable courage. Caregivers, radiation oncologists, medical physicists, and care teams work endlessly to deliver the best possible outcomes.

At TibaRay, our hearts and daily efforts are with this community. We believe that supporting patients means fighting for a future where treatment is not only effective, but faster, gentler, and far less burdensome on the human body.

Our mission—Curing Cancer in a FLASH™—is rooted in that deep hope. By working to compress radiation delivery into fractions of a second, we aim to "freeze" natural physiological motion, help protect surrounding healthy tissue, and give patients more precious time away from the treatment table.

Today and every day, we honor the extraordinary resilience of survivors, stand with those currently in treatment, and thank the healthcare teams guiding them forward! You inspire everything we do.

⚡ Follow our journey and see how we’re turning hope into action: https://na2.hubs.ly/H08m5Ht0

Proud to have Kirk Bertsche representing TibaRay at the 2026 joint international conference of the 28th CAARI (Applicati...
10/11/2026

Proud to have Kirk Bertsche representing TibaRay at the 2026 joint international conference of the 28th CAARI (Application of Accelerators in Research and Industry), 57th SNEAP, and 8th WOTWISI!

Kirk recently presented on “Demonstration of Battery-Operated 3 MV Linac for Threat Detection” as part of the conference’s Security & Defense Applications: Accelerator-Based Systems session.

Held September 13–16 at the University of North Texas in Denton, Texas, CAARI brings together researchers, engineers, and industry leaders from around the world to explore the application of accelerator technology across research and industry.

We’re proud to be part of this community and to have Kirk representing TibaRay at this year’s conference.

Learn more about TibaRay, our technology, and our community raise: https://na2.hubs.ly/H08jF5v0

For nearly 70 years, radiation oncology has relied on linear accelerator architectures that are massive, costly, and for...
10/09/2026

For nearly 70 years, radiation oncology has relied on linear accelerator architectures that are massive, costly, and force a compromise between dose intensity and collateral tissue damage.

TibaRay is changing that.

Medical Product Outsourcing (MPO) recently featured our latest commercial milestone: the first Galactica™ cancer treatment systems have officially entered manufacturing.

Key highlights from the article:
- The First New Class in Decades: Built on high-gradient accelerator technology invented at Stanford University, Galactica™ represents the first fundamentally new class of medical linear accelerator in nearly seven decades.
- Upright Clinical Integration: Designed to integrate directly into Leo Cancer Care’s upright patient-positioning platform, treating patients sitting or standing to freeze motion, improve comfort, and reduce the system footprint.
- Tier-1 Clinical Deployment: The first clinical installation is slated for later this year at Mayo Clinic.
- The Path to Conformal FLASH: Serves as the hardware engine for ultra-rapid FLASH radiotherapy, delivering curative doses in milliseconds to spare healthy tissue while preserving tumor kill.

As CEO Thinh Tran shared with MPO: "Moving into manufacturing means Galactica is coming to life. We have reached a major engineering milestone that transforms years of innovation into a technology ready for real-world clinical deployment."

Our doors are currently open to investors through our community raise on Wefunder as we scale production in our 24,000 sq. ft. Silicon Valley facility.

Continue to follow our journey here:
👉 https://na2.hubs.ly/H08js4-0

09/30/2026

Cancer treatment has always faced a difficult challenge: effectively treating the tumor while limiting the impact on surrounding healthy tissue.

FLASH is opening new possibilities for doing both.

Hear Dr. Bill Loo, Professor of Radiation Oncology at Stanford Medicine and TibaRay Co-Founder, explain the potential behind this technology and what it could mean for the future of cancer treatment.

Invest or Increase Your Investment, https://wefunder.com/tibaray/invest

09/28/2026

What if cancer treatment could be faster and more precise?

Dr. Bill Loo, Professor of Radiation Oncology at Stanford Medicine and TibaRay Co-Founder, shares what revealed the potential of this technology and how FLASH radiotherapy could open new possibilities for treating tumors while limiting exposure to surrounding healthy tissue.

Invest or Increase Your Investment, https://wefunder.com/tibaray/invest

09/24/2026

What if cancer treatment could happen in a fraction of a second?

TibaRay is building a future where precision radiation technology could transform the way cancer is cured.

Learn more about our mission to advance the future of cancer care at Wefunder.com/TibaRay.

🎯 Three challenges in radiation therapy: too slow, too damaging, and too costly.Those challenges drive our work toward a...
09/21/2026

🎯 Three challenges in radiation therapy: too slow, too damaging, and too costly.

Those challenges drive our work toward a different treatment experience: Fast. Precise. Accessible.

Our breakthrough solution starts with the Galactica™ linear accelerator platform, which we’re developing to enable three advances in radiotherapy:
✅ FLASH therapy: Radiotherapy in a fraction of a second, not minutes
✅ Freeze motion: Ultimate targeting accuracy
✅ Less collateral tissue damage: No compromise on tumor killing

A little detour from our theme of three… 😊

Lehigh University’s Startup Academy recently showcased TibaRay on the Nasdaq Tower, sharing our mission of Curing Cancer in a FLASH™. We’re proud of our team and the work that earned this recognition.

Here’s to many more milestones together!

Invest or Increase Your Investment here: https://vist.ly/5jb88

09/21/2026

The next generation of cancer care won’t happen by standing still.

It will take bold ideas, new technology, and people willing to support what comes next.

TibaRay is advancing a new vision for cancer radiotherapy. Discover how you can be part of the future at Wefunder.com/TibaRay.

Address

Fremont, CA

Website

,

Alerts

Be the first to know and let us send you an email when TibaRay, Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category